DiaMedica Therapeutics (DMAC) to Release Quarterly Earnings on Monday

DiaMedica Therapeutics (NASDAQ:DMAC) will likely be releasing its earnings data before the market opens on Monday, March 17th. Analysts expect DiaMedica Therapeutics to post earnings of ($0.17) per share for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.

DiaMedica Therapeutics Price Performance

Shares of DiaMedica Therapeutics stock opened at $5.77 on Friday. The stock has a market cap of $246.73 million, a P/E ratio of -10.30 and a beta of 1.52. The stock’s 50 day simple moving average is $5.95 and its 200-day simple moving average is $5.07. DiaMedica Therapeutics has a 1-year low of $2.14 and a 1-year high of $6.82.

DiaMedica Therapeutics Company Profile

DiaMedica Therapeutics Inc, a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from serious diseases with a focus on acute ischemic stroke. Its lead candidate is DM199, a pharmaceutically active recombinant form of the human tissue kallikrein-1 protein, which is in Phase II/III trials for the treatment of acute ischemic stroke, as well as that is in Phase 2 to treat cardio-renal disease.